Financings In the first quarter of 2012, biopharma start-ups raised $338.1 million – 51% less than the previous quarter but a 62% hike from Q1 2011. Series B rounds dominated, generating 43% of the to
IN VITRO DIAGNOSTICS Iverson Genetic Diagnostics Inc. Vanderbilt University Iverson Genetic Diagnostics licenses breast cancer testing rights from Vanderbilt University Vanderbilt University has
Exhibit 1 Top Alliances In January 2012 *Potential Deal Value is the sum of up-front fees plus pre-commercialization money Elsevier’s Strategic Transactions Exhibit 2 Top Mergers & Acquisitions In Jan